WESPAC Advisors SoCal LLC Has $1.77 Million Stake in SPDR S&P Biotech ETF $XBI

WESPAC Advisors SoCal LLC raised its holdings in SPDR S&P Biotech ETF (NYSEARCA:XBI) by 174.9% in the 1st quarter, HoldingsChannel reports. The firm owned 13,858 shares of the exchange traded fund’s stock after purchasing an additional 8,816 shares during the quarter. WESPAC Advisors SoCal LLC’s holdings in SPDR S&P Biotech ETF were worth $1,770,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds also recently bought and sold shares of the business. AQR Capital Management LLC raised its holdings in shares of SPDR S&P Biotech ETF by 77.1% in the first quarter. AQR Capital Management LLC now owns 4,978 shares of the exchange traded fund’s stock valued at $404,000 after buying an additional 2,167 shares during the last quarter. Marshall Wace LLP grew its holdings in SPDR S&P Biotech ETF by 102.3% during the 2nd quarter. Marshall Wace LLP now owns 4,023 shares of the exchange traded fund’s stock worth $334,000 after acquiring an additional 179,029 shares during the last quarter. The Manufacturers Life Insurance Company bought a new stake in SPDR S&P Biotech ETF during the 2nd quarter worth about $260,000. Ameriprise Financial Inc. increased its position in SPDR S&P Biotech ETF by 123.0% in the 2nd quarter. Ameriprise Financial Inc. now owns 872,796 shares of the exchange traded fund’s stock valued at $72,542,000 after acquiring an additional 481,408 shares in the last quarter. Finally, EP Wealth Advisors LLC increased its position in SPDR S&P Biotech ETF by 3.7% in the 2nd quarter. EP Wealth Advisors LLC now owns 5,379 shares of the exchange traded fund’s stock valued at $446,000 after acquiring an additional 193 shares in the last quarter.

SPDR S&P Biotech ETF Stock Performance

Shares of NYSEARCA XBI opened at $140.72 on Friday. SPDR S&P Biotech ETF has a 1-year low of $80.90 and a 1-year high of $143.46. The company has a 50-day moving average of $133.56 and a two-hundred day moving average of $127.70. The company has a market cap of $8.98 billion, a PE ratio of 11.47 and a beta of 0.85.

About SPDR S&P Biotech ETF

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges. The Biotech Index is a modified equal weight index.